000952 广济药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-12.374-9.7873.3957.7666.398
总资产报酬率 ROA (%)-5.167-5.1002.2285.4673.985
投入资产回报率 ROIC (%)-5.926-5.7542.4676.0664.471

边际利润分析
销售毛利率 (%)23.00527.40536.99838.34740.634
营业利润率 (%)-36.893-19.1187.62015.04614.072
息税前利润/营业总收入 (%)-28.579-13.1339.44017.83818.208
净利润/营业总收入 (%)-37.313-20.6575.97813.46910.215

收益指标分析
经营活动净收益/利润总额(%)97.22388.74779.03164.45059.206
价值变动净收益/利润总额(%)2.1317.12610.49015.05836.495
营业外收支净额/利润总额(%)0.282-0.275-1.1634.939-9.857

偿债能力分析
流动比率 (X)0.9841.2531.5371.3121.525
速动比率 (X)0.6730.9071.1991.0071.170
资产负债率 (%)60.86754.03739.60229.19131.006
带息债务/全部投入资本 (%)40.91134.99429.15519.60219.099
股东权益/带息债务 (%)108.190147.478230.828403.704403.351
股东权益/负债合计 (%)63.38883.286153.619244.523223.719
利息保障倍数 (X)-3.395-2.2144.9498.8763.373

营运能力分析
应收账款周转天数 (天)121.032100.44186.86665.78653.293
存货周转天数 (天)251.915174.906138.366122.049132.844